| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/02/1996 | US5504193 Extraction methods for preparing thromboplastin reagents |
| 04/02/1996 | US5504191 Human cancer inhibitory pentapeptide methyl esters |
| 04/02/1996 | US5504190 Equimolar multiple oligomer mixtures, especially oligopeptide mixtures |
| 04/02/1996 | US5504189 Peptides, their preparation and use |
| 04/02/1996 | US5504188 Crystallization of lys(b28)pro(b29)-human insulin zinc salt at a ph of about 5.5 to 6.5 from a solution also containing acetic acid, citric acid, glycine or phenolic compound |
| 04/02/1996 | US5504080 Benzo-fused lactams |
| 04/02/1996 | US5504071 Compounds with a sequence of three radicals, the central one being α-a |
| 04/02/1996 | US5504070 Inhibitors of the conversion of big endothelin to endothelin |
| 04/02/1996 | US5504069 Inhibition of trauma-induced tumor growth |
| 04/02/1996 | US5504068 Topical preparations containing cyclosporin |
| 04/02/1996 | US5504067 Treatment of bleeding with modified tissue factor in combination with FVII |
| 04/02/1996 | US5504065 Agent for treating or preventing AIDS using human urine trypsin inhibitor |
| 04/02/1996 | US5504064 Administering truncated tissue factor protein lacking amino acids that bind to phospholipid membranes with activator of endogenous factor vii to clot blood |
| 04/02/1996 | US5504003 Macrophage inflammatory protein-3 and -4 |
| 04/02/1996 | US5504001 Protein |
| 04/02/1996 | US5503989 Production of peptide amides |
| 04/02/1996 | US5503978 Method for identification of high affinity DNA ligands of HIV-1 reverse transcriptase |
| 04/02/1996 | US5503973 Method for inhibition of viral morphogenesis |
| 04/02/1996 | US5503853 Prophylactic and therapeutic applications of peroxidases |
| 04/02/1996 | US5503850 Large unilamellar vesicles encapsulating a plasminogen activator |
| 04/02/1996 | US5503841 Administering to enhance immune response to vaccine |
| 04/02/1996 | US5503833 VP6 encapsulated drug delivery |
| 04/02/1996 | US5503831 Foodstuff; obesity treatment |
| 04/02/1996 | US5503828 Alpha interferon composition and method for its production from human peripheral blood leukocytes |
| 04/02/1996 | US5503827 Process for the production of multi-dose pharmaceutical preparations containing isolated or recombinantly produced human protein for infusion or injection purposes |
| 04/02/1996 | US5503558 Osseointegration promoting implant composition, implant assembly and method therefor |
| 03/29/1996 | CA2133253A1 Compositions with enhanced osteogenic potential, methods for making the same and therapeutic uses thereof |
| 03/28/1996 | WO1996009551A1 Detection and treatment of cancer |
| 03/28/1996 | WO1996009543A1 In vitro models of cns function and dysfunction |
| 03/28/1996 | WO1996009411A1 Antigen binding peptides (abtides) from peptide libraries |
| 03/28/1996 | WO1996009408A1 Human galactokinase gene |
| 03/28/1996 | WO1996009399A2 Chimeric adenovirus for gene delivery |
| 03/28/1996 | WO1996009398A1 Gene constructs encoding crop-protecting agents, as well as transformed plants containing and expressing such constructs, and methods of controlling plague organisms and pathogens in crops |
| 03/28/1996 | WO1996009392A1 RIBOZYME TREATMENT OF DISEASES OR CONDITIONS RELATED TO LEVELS OF PLASMA LIPOPROTEIN (a) [Lp(a)] BY INHIBITING APOLIPOPROTEIN (a) [APO(a)] |
| 03/28/1996 | WO1996009390A2 A novel fungal multisubunit protein complex critical for expression of fungal proteins |
| 03/28/1996 | WO1996009389A2 Recombinant macrophage migration inhibitory factor; expression in escherichia coli and purification of recombinant protein |
| 03/28/1996 | WO1996009387A1 Cancer treatment by expression of differentiation factor receptor |
| 03/28/1996 | WO1996009385A1 Anti-sickling beta-globin protein, compositions and methods for treating sickle cell disease |
| 03/28/1996 | WO1996009384A1 Eph receptor ligands, and uses related thereto |
| 03/28/1996 | WO1996009382A1 gp130 LACKING THE TRANSMEMBRANE DOMAIN |
| 03/28/1996 | WO1996009380A1 Method of enhancing expression of mhc class i molecules bearing endogenous peptides |
| 03/28/1996 | WO1996009376A1 Therapeutic grade thrombin production and products |
| 03/28/1996 | WO1996009375A1 Dna encoding human papillomavirus type 6a |
| 03/28/1996 | WO1996009374A1 Human galactokinase gene |
| 03/28/1996 | WO1996009324A1 Ecdn protein and dna coding for the same |
| 03/28/1996 | WO1996009323A1 Il-1 receptor antagonists with enhanced inhibitory activity |
| 03/28/1996 | WO1996009322A2 Synducin mediated modulation of tissue repair |
| 03/28/1996 | WO1996009320A1 Antigenic polypeptide of chlamydia pneumoniae |
| 03/28/1996 | WO1996009318A1 Method and pharmaceutical composition for prevention and treatment of brain damage |
| 03/28/1996 | WO1996009317A1 Cloning of an insulin-dependent membrane aminopeptidase from glut-4 vesicles |
| 03/28/1996 | WO1996009315A1 Dna photocleavage using texaphyrins |
| 03/28/1996 | WO1996009311A1 Human transcription factor iia |
| 03/28/1996 | WO1996009078A1 Formulations for delivery of osteogenic proteins |
| 03/28/1996 | WO1996009074A1 Use of a non-mammalian dna virus to express an exogenous gene in a mammalian cell |
| 03/28/1996 | WO1996009073A1 Biodegradable medicinal polymer assembly with supermolecular structure |
| 03/28/1996 | WO1996009071A1 Conjugate consisting of an active substance and a non-exogenous native protein |
| 03/28/1996 | WO1996009067A1 Osteoclast-specific glycoprotein for diagnosis and treatment of osteoporosis |
| 03/28/1996 | WO1996009066A2 Method of treatment of human immunodeficiency virus (hiv) infection |
| 03/28/1996 | WO1996009065A1 Method of treating hypertension in pregnant mammals |
| 03/28/1996 | WO1996009064A1 Method and pharmaceutical composition for prevention and treatment of brain damage |
| 03/28/1996 | WO1996009063A1 Use of muramyl peptide compounds |
| 03/28/1996 | WO1996009062A1 Polypeptide agonists and antagonists of human interleukin-8 |
| 03/28/1996 | WO1996009059A1 Improved method and composition for the treatment of ulcers |
| 03/28/1996 | WO1996009043A1 Methods for the treatment of inflammatory joint disease |
| 03/28/1996 | WO1996008970A1 COMPOSITIONS AND METHODS FOR THE ABROGATION OF CELLULAR PROLIFERATION UTILIZING THE HUMAN IMMUNODEFICIENCY VIRUS Vpr PROTEIN |
| 03/28/1996 | WO1996007738A3 Modified human c3 proteins |
| 03/28/1996 | DE4441197C1 Schizosaccharomyces pombe expression plasmids |
| 03/28/1996 | DE4433890A1 Konjugat aus einem Wirkstoff und einem nicht als körperfremd angesehenen, nativen Protein Conjugate of an active agent and a non-prestigious as foreign, native protein |
| 03/28/1996 | CA2200835A1 Use of a non-mammalian dna virus to express an exogenous gene in a mammalian cell |
| 03/28/1996 | CA2200724A1 Human galactokinase gene |
| 03/28/1996 | CA2200709A1 In vitro models of cns function and dysfunction |
| 03/28/1996 | CA2200684A1 Antigen binding peptides (abtides) from peptide libraries |
| 03/28/1996 | CA2200611A1 Cancer treatment by expression of differentiation factor receptor |
| 03/28/1996 | CA2200571A1 Dna photocleavage using texaphryns |
| 03/28/1996 | CA2200570A1 Use of muramyl peptide compounds |
| 03/28/1996 | CA2200434A1 Gene constructs encoding crop-protecting agents, as well as transformed plants containing and expressing such constructs, and methods of controlling plague organisms and pathogensin crops |
| 03/28/1996 | CA2200354A1 Cloning of an insulin-dependent membrane aminopeptidase from glut-4 vesicles |
| 03/28/1996 | CA2199748A1 A novel fungal multisubunit protein complex critical for expression of fungal proteins |
| 03/28/1996 | CA2199727A1 Ribozyme treatment of diseases or conditions related to levels of plasma lipoprotein (a) ¬lp(a)| by inhibiting apolipoprotein (a) ¬apo(a)| |
| 03/28/1996 | CA2199022A1 Method of treating hypertension in pregnant mammals |
| 03/28/1996 | CA2197490A1 Detection and treatment of cancer |
| 03/28/1996 | CA2176383A1 Supramolecular-structure biodegradable polymeric assembly for drug delivery |
| 03/27/1996 | EP0703242A1 Human-origin tumor cell proliferation inhibiting factor |
| 03/27/1996 | EP0703222A1 3-aminoazepine compound and pharmaceutical use thereof |
| 03/27/1996 | EP0702960A1 Liquid globulin composition for intravenous injection, process for producing the same, and method of inhibiting globulin dimer increase in said composition |
| 03/27/1996 | EP0702959A1 Cross-linked gelatin gel preparation containing basic fibroblast growth factor |
| 03/27/1996 | EP0702958A1 Vaginal preparation containing physiologically active peptide |
| 03/27/1996 | EP0702723A1 Biocompatible implant for the expression and secretion in vivo of a therapeutical compound |
| 03/27/1996 | EP0702722A1 Plasmids suitable for gene therapy |
| 03/27/1996 | EP0702719A1 Process for the sterilization of biological compositions and the product produced thereby |
| 03/27/1996 | EP0702717A1 Generation, concentration and efficient transfer of vsv-g pseudotyped retroviral vectors |
| 03/27/1996 | EP0702716A1 Ribozyme gene therapy for hiv infection and aids |
| 03/27/1996 | EP0702696A1 Trifunctional antithrombin and antiplatelet peptides |
| 03/27/1996 | EP0702695A1 CLONING, EXPRESSION AND USES OF $i(DORSALIN-1) |
| 03/27/1996 | EP0702692A1 Regulation of antigen presentation |
| 03/27/1996 | EP0702691A1 New thiodepsipeptide isolated from a marine actinomycete |
| 03/27/1996 | EP0702572A1 Biological adhesive composition and method of promoting adhesion between tissue surfaces |
| 03/27/1996 | EP0702567A1 Methods and compositions for aiding periodontal tissue regeneration |
| 03/27/1996 | EP0702566A1 Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity |
| 03/27/1996 | EP0702563A1 Compositions and methods for treating cancer and hyperproliferative disorders |